April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
The Effect of Modified Eggs on Macular Pigment
Author Affiliations & Notes
  • E. R. Kelly
    Ophthalmology, University Eye Clinic Maastricht, Maastricht, The Netherlands
  • J. Plat
    Human Biology,
    University of Maastricht, Maastricht, The Netherlands
  • G. R. M. M. Haenen
    Pharmacology and Toxicology,
    University of Maastricht, Maastricht, The Netherlands
  • A. Bast
    Pharmacology and Toxicology,
    University of Maastricht, Maastricht, The Netherlands
  • R. P. Mensink
    Human Biology,
    University of Maastricht, Maastricht, The Netherlands
  • T. T. J. M. Berendschot
    Ophthalmology, University Eye Clinic Maastricht, Maastricht, The Netherlands
  • Footnotes
    Commercial Relationships  E.R. Kelly, None; J. Plat, None; G.R.M.M. Haenen, None; A. Bast, None; R.P. Mensink, None; T.T.J.M. Berendschot, None.
  • Footnotes
    Support  SenterNovem
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 1711. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E. R. Kelly, J. Plat, G. R. M. M. Haenen, A. Bast, R. P. Mensink, T. T. J. M. Berendschot; The Effect of Modified Eggs on Macular Pigment. Invest. Ophthalmol. Vis. Sci. 2009;50(13):1711.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : There is increasing evidence that suggests a possible beneficial effect of lutein and zeaxanthin on macular degeneration. Eggs, containing ample amounts of cholesterol, present themselves as a suitable vehicle to attain adequate absorption. We here present the results of a trial on the effect of daily egg consumption on plasma levels and macular pigment optical density (MPOD).

Methods: : For this double blinded, three months interventional trial, 80 healthy subjects were recruited and randomized into 4 groups, stratified for age and gender. Group 1 consumed lutein-enriched eggs, group 2 zeaxanthin-enriched eggs, whereas group 3 had normal eggs daily. The control group 4 was not blinded and received no product. Serum lutein, zeaxanthin and MPOD were measured at baseline, week 6-7 and at endpoint. MPOD measurements were performed using the macular pigment screener (MPS), the macular pigment reflectometer (MPR), and a scanning laser ophthalmoscope (SLO).

Results: : Baseline characteristics were comparable in the four groups. A regression analysis with serum lutein endpoint concentration as the dependent variable, and baseline serum lutein concentration and groups as the independent variables showed the lutein-enriched eggs to significantly increase lutein plasma levels (P<0.001). A similar analysis for zeaxanthin showed the zeaxanthin-enriched eggs to cause a significant increase of the plasma zeaxanthin concentration (P<0.001). A regression analysis of the SLO measurements with endpoint MPOD as dependent, and baseline MPOD and diets as independents showed a significant contribution of normal egg, lutein- , and zeaxanthin-enriched eggs as compared to the control group (P=0.044, P=0.019, and P=0.014 respectively). The MPR-lutein measurement also showed the lutein-enriched eggs to contribute to a significant increase in MPOD (P= 0.048).

Conclusions: : In this study, we showed a significant effect of the lutein- and zeaxanthin-enriched eggs on the plasma concentrations of lutein, zeaxanthin, and MPOD. This result poses the enriched-eggs as an effective vehicle for the absorption of lutein and zeaxanthin.

Clinical Trial: : www.clinicaltrials.gov NCT00527553

Keywords: clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • macular pigment • age-related macular degeneration 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×